Three-month follow-up of pulmonary embolism in patients with COVID-19
- PMID: 33662797
- PMCID: PMC7908844
- DOI: 10.1016/j.thromres.2021.02.023
Three-month follow-up of pulmonary embolism in patients with COVID-19
Keywords: COVID-19; Pulmonary embolism.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: L.N.R. has received speaker fees and a travel grant from Bayer, and an investigator-initiated research grant and a travel grant from Sanofi. J.C. has received a travel grant from Mitsubishi Pharma and honoraria from Bayer and Sanofi. C.R. has received unrestricted research grants from Baxter, SOBI, BioMarin. R.K.P. has received speaker fees from Bayer. E.G. has received honoraria from Bayer. R.A. reports grants from Bayer; personal fees from Bayer, Pfizer, Medtronic, and Sanofi; and nonfinancial support from Bayer, Pfizer, and Sanofi. The remaining authors declare no competing financial interests.
Comment on
-
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.J Thromb Haemost. 2020 Aug;18(8):1859-1865. doi: 10.1111/jth.14929. J Thromb Haemost. 2020. PMID: 32459046 Free PMC article. No abstract available.
References
-
- Piazza G., Morrow D.A. Diagnosis, management, and pathophysiology of arterial and venous thrombosis in COVID-19. JAMA. 2020;324:2548–2549. - PubMed
-
- Schulman S., Kearon C. Subcommittee on Control of Anticoagulation of the S, Standardization Committee of the International Society on T, Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J. Thromb. Haemost. 2005;3(4):692–694. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
